Filter
1195
Filtered Results: 1195
Text search:
rifampicin
Featured
Recommendations
140
New Publications
299
Language
Document type
No document type
748
Guidelines
181
Studies & Reports
116
Manuals
65
Strategic & Response Plan
32
Training Material
20
Fact sheets
20
Situation Updates
6
Infographics
4
Brochures
1
App
1
Resource Platforms
1
Countries / Regions
India
61
Western and Central Europe
60
Eastern Europe
36
South Africa
28
Nepal
27
Latin America and the Carribbean
22
Kenya
21
Global
19
Argentina
19
Namibia
18
Colombia
16
Nigeria
16
Tanzania
16
Peru
15
Paraguay
14
Uganda
14
Ethiopia
14
Zambia
14
Germany
13
Bangladesh
13
Indonesia
13
Rwanda
12
Malawi
12
El Salvador
11
Senegal
11
Myanmar / Burma
11
Ukraine
10
Philippines
10
Bolivia
10
Brazil
10
South–East Asia Region
9
Mozambique
8
Cambodia
8
Asia
8
Congo, Democratic Republic of
8
Cameroon
7
Russia
7
Africa
6
Tajikistan
5
Benin
5
Zimbabwe
5
Uruguay
5
Ecuador
5
Eswatini/ Swaziland
5
Ghana
4
Chile
4
Burkina Faso
4
Venezuela
4
Botswana
4
Liberia
4
Madagascar
4
Pakistan
4
Lesotho
3
Haiti
3
Georgia
3
Bhutan
3
Timor Leste/ East Timor
2
Sierra Leone
2
Syria
2
Armenia
2
Jordan
2
Eastern Europe and Central Asia
2
Sri Lanka
2
Central African Republic
2
North Macedonia
1
North Korea
1
Switzerland
1
Thailand
1
Mexico
1
Serbia
1
Gambia
1
Togo
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Morocco
1
Guinea
1
USA
1
Dominican Republic
1
Saudi Arabia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Turkmenistan
1
France
1
Tunisia
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Nicaragua
1
Sudan
1
Yemen
1
Romania
1
Greece
1
Honduras
1
Mali
1
Libya
1
Iraq
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
469
Clinical Guidelines
146
Women & Child Health
25
Public Health
23
Capacity Building
16
Pharmacy & Technologies
14
Key Resources
10
Toolboxes
TB
545
HIV
108
NTDs
72
AMR
44
Pharmacy
41
Refugee
18
Polio
13
COVID-19
9
Ebola & Marburg
8
Caregiver
6
Mental Health
5
Conflict
5
Rapid Response
3
Global Health Education
3
Natural Hazards
2
Planetary Health
1
Health Financing Toolbox
1
NCDs
1
Malaria
1
Zika
1
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte...
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover...
Malaria in pregnancy is a significant health problem in malaria-endemic areas. It not only causes substantial childhood morbidity and mortality but also increases the risks of adverse events for pregnant women and their developing fetuses. Most of the burden in these areas is due to infection with P...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb...
The purpose of this guide is to provide updated clinical guidance on TB/HIV, with an emphasis on diagnostic aspects—including new techniques—as well as current treatment, while maintaining a public health approach. By compiling and consolidating the latest World Health Organization recommendatio...
This policy brief presents a summary of current evidence on vulnerability to TB and proposes interventions for equitable, person-centred, and human rights-based TB prevention and care. It aligns with WHO policies and guidance on TB prevention and screening, management of TB and comorbidities, access...
National tuberculosis (TB) prevalence surveys provide a nationally representative measurement of the burden of TB disease in the population, at a given point in time. Repeat surveys allow assessment of trends and tracking of progress towards national and global targets for reductions in TB disease b...
Despite being a preventable and curable infectious disease, tuberculosis (TB) has continued to elude global controll efforts. In 2023, 8.2 milion people with TB were diagnosed and notified to the WHO, the hightest number ever reported since WHO began tracking.
Buruli ulcer (BU) is a skin-related neglected tropical disease (skin NTD) caused by infection with
Mycobacterium ulcerans. BU is the third most common mycobacterial disease after tuberculosis and leprosy
in people who are not immunocompromised. The infection manifests in non-ulcerative forms as no...
This document on logistics management information systems (LMIS) was developed to address the increasing need for harmonization and standardization of core indicators for managing medicines and health products for neglected tropical diseases (NTDs) at country level (i.e. for last-mile logistics). It...
MEDBOX Annual Report 2024
recommended
The MEDBOX Annual Report provides an overview of the most important projects of the past year
Norma técnica para el control y la eliminación de la tuberculosis programa nacional de control y eliminación de la tuberculosis - Actualización 2021 Resolución Exenta N°60 del Ministerio de Salud, con fecha 14 de enero de 2022
En la presente guía de capacitación se explica cómo reconocer los signos y los síntomas de las enfermedades tropicales desatendidas de la piel a partir de sus características visibles. También contiene información sobre cómo diagnosticar y tratar los problemas frecuentes de la piel que puede...
fin à la Tuberculose
26 de abril del 2022. La Organización Panamericana de la Salud presenta estas consideraciones con el fin de apoyar la toma de decisiones relativa al manejo de pacientes con COVID-19 en la Región de las Américas. Las recomendaciones tienen en cuenta la evidencia más reciente, el estado de vacunac...
